Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

Author(s): Lingyun Zhang, Lubna Nadeem, Kristin Connor, Guoxiong Xu

Journal Name: Current Cancer Drug Targets

Volume 16 , Issue 5 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Epithelial ovarian cancer (EOC) is the most lethal disease among gynecologic malignancies. Despite increasing knowledge of ovarian cancer biology and advances in treatment efficacy, the survival rate of patients with EOC has not improved over the past two decades. Patients with an advanced disease often relapse due to the development of chemoresistance. Recent in vivo and in vitro studies have shown insight into the mechanisms of such drug resistance, including a potential role for microRNAs (miRNA, miR) in the process of chemoresistance. In this review, we provide an overview of current therapeutic targets of miRNA-associated chemoresistance in EOC and discuss potential therapeutic values and molecular mechanisms by which miRNAs influence the development and reversal of chemoresistance.

Keywords: Ovarian cancer, relapse, drug resistance, miRNA target, oncogene, tumor suppressor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 04 April, 2016
Page: [429 - 441]
Pages: 13
DOI: 10.2174/1568009616666160404121105
Price: $65

Article Metrics

PDF: 41